Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Toovey

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Travel Medicine and Infectious Disease|June 18, 2014
Malaria chemoprophylaxis regimens: a descriptive drug utilization studyMarlene Bloechliger, Patricia Schlagenhauf, Stephen Toovey, et al.
Nature Reviews. Neurology|October 15, 2014
Maternal immune activation and abnormal brain development across CNS disordersIrene Knuesel, Laurie Chicha, Markus Britschgi, et al.
Clinical Pharmacology and Therapeutics|November 17, 2023
An Observational Study on the Pharmacokinetics of Oseltamivir in Lactating Influenza PatientsEszter Fodor, Regina N Nagy, András Nógrádi, et al.
Travel Medicine and Infectious Disease|November 5, 2020
Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysisNancy A Dreyer, Matthew Reynolds, Christina DeFilippo Mack, et al.
Journal of Comparative Effectiveness Research|September 23, 2022
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control designMatthew W Reynolds, Alex Secora, Alice Joules, et al.
BMJ Open|June 19, 2023
Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registryJoan Largent, Yiqiong Xie, Kendall B Knuth, et al.
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
The Journal of Infectious Diseases|September 14, 2010
Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient RegistryWiku Adisasmito, Paul K S Chan, Nelson Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
H5N1 avian influenza in childrenAhmet Faik Oner, Nazim Dogan, Viktor Gasimov, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Travel Medicine and Infectious Disease|June 18, 2014
Malaria chemoprophylaxis regimens: a descriptive drug utilization studyMarlene Bloechliger, Patricia Schlagenhauf, Stephen Toovey, et al.
Nature Reviews. Neurology|October 15, 2014
Maternal immune activation and abnormal brain development across CNS disordersIrene Knuesel, Laurie Chicha, Markus Britschgi, et al.
Clinical Pharmacology and Therapeutics|November 17, 2023
An Observational Study on the Pharmacokinetics of Oseltamivir in Lactating Influenza PatientsEszter Fodor, Regina N Nagy, András Nógrádi, et al.
Travel Medicine and Infectious Disease|November 5, 2020
Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysisNancy A Dreyer, Matthew Reynolds, Christina DeFilippo Mack, et al.
Journal of Comparative Effectiveness Research|September 23, 2022
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control designMatthew W Reynolds, Alex Secora, Alice Joules, et al.
BMJ Open|June 19, 2023
Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registryJoan Largent, Yiqiong Xie, Kendall B Knuth, et al.
Basic & Clinical Pharmacology & Toxicology|May 20, 2011
Absence of adverse effects of oseltamivir on sleep: a double-blind, randomized study in healthy volunteers in JapanNaohisa Uchimura, Hiroo Kuwahara, Yuji Kumagai, et al.
Advances in Therapy|October 12, 2012
Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated reviewStephen Toovey, Eric P Prinssen, Craig R Rayner, et al.
The Journal of Infectious Diseases|September 14, 2010
Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient RegistryWiku Adisasmito, Paul K S Chan, Nelson Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
H5N1 avian influenza in childrenAhmet Faik Oner, Nazim Dogan, Viktor Gasimov, et al.
Pageof 6